blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1648920

EP1648920 - CAR LIGAND-BINDING DOMAIN POLYPEPTIDE CO-CRYSTALLIZED WITH A LIGAND, AND METHODS OF DESIGNING LIGANDS THAT MODULATE CAR ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.07.2009
Database last updated on 16.11.2024
Most recent event   Tooltip10.07.2009Application deemed to be withdrawnpublished on 12.08.2009  [2009/33]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza
Philadelphia, PA 19101 / US
[2006/17]
Inventor(s)01 / COLLINS, Jon Loren, GlaxoSmithKline
Five Moore Drive, PO Box 13398, Res. Triangle Park
North Carolina 27709 / US
02 / LAMBERT, III Millard Hurst, GlaxoSmithKline
Five Moore Drive, PO Box 13398, Res. Triangle Park
North Carolina 27709 / US
03 / WISELY, George Bruce, GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
04 / XU, Xiaoyun GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
 [2006/17]
Representative(s)Easeman, Richard Lewis, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2006/17]Easeman, Richard Lewis, et al
GlaxoSmithKline Corporate Intellectual Property (CN).25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date04801899.816.07.2004
[2006/17]
WO2004US23092
Priority number, dateUS20030488415P18.07.2003         Original published format: US 488415 P
[2006/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005019239
Date:03.03.2005
Language:EN
[2005/09]
Type: A2 Application without search report 
No.:EP1648920
Date:26.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2005 takes the place of the publication of the European patent application.
[2006/17]
Search report(s)International search report - published on:US02.04.2009
ClassificationIPC:C07K14/00
[2009/22]
CPC:
C07K14/4702 (EP,US); C07D235/30 (EP,US); C07K2299/00 (EP,US)
Former IPC [2006/17]C07K1/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/17]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:GEMEINSAM MIT EINEM LIGANDEN KRISTALLISIERTES POLYPEPTID DER CAR-LIGANDENBINDUNGSDOMÄNE UND VERFAHREN ZUR ENTWICKLUNG VON LIGANDEN, DIE DIE CAR-AKTIVITÄT MODULIEREN[2006/17]
English:CAR LIGAND-BINDING DOMAIN POLYPEPTIDE CO-CRYSTALLIZED WITH A LIGAND, AND METHODS OF DESIGNING LIGANDS THAT MODULATE CAR ACTIVITY[2006/17]
French:POLYPEPTIDE DE DOMAINE DE LIAISON AU LIGAND DU RECEPTEUR CAR CO-CRISTALLISE AVEC UN LIGAND, ET PROCEDES DE CONCEPTION DE LIGANDS MODULANT L'ACTIVITE DU RECEPTEUR CAR[2006/17]
Entry into regional phase16.02.2006National basic fee paid 
16.02.2006Search fee paid 
16.02.2006Designation fee(s) paid 
16.02.2006Examination fee paid 
Examination procedure16.02.2006Amendment by applicant (claims and/or description)
16.02.2006Examination requested  [2006/17]
06.01.2009Application deemed to be withdrawn, date of legal effect  [2009/33]
19.03.2009Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/33]
Fees paidRenewal fee
10.07.2006Renewal fee patent year 03
04.07.2007Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.200805   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - DUSSAULT, I. ET AL., "A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity", (2002), vol. 22, pages 5270 - 5280
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.